GENE ONLINE|News &
Opinion
Blog

2022-09-16| COVID-19

The COVID-19 Pandemic: Is Omicron the Last Variant?

by Max Heirich
Share To
The COVID-19 pandemic saw the rise of multiple strains that put the companies manufacturing vaccines through their paces to keep up. With the FDA approving new vaccines for the latest substrains of the Omicron Variant, it seems that COVID-19 Cases are finally slowing down. These Emergency Use Authorizations were pushed through in a manner of days, marking them as some of the fastest ever in FDA history. However, they were based upon mountains of prior research done on their predecessors for prior strains as well as the heavily mutated Omicron Strains.
How do these vaccines function differently from their prior counterparts? And will these boosters bring about the end of the COVID-19 pandemic after so many strain mutations?

GO Prime with only $1.49 now

LATEST
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15
Tribal Leaders Warn Senators: Federal Health Funding Cuts Threaten Native American Health.
2025-05-14
Health Secretary Kennedy Retracts Parts of Agency Reorganization Plan During Combative Congressional Hearing
2025-05-14
SURMOUNT-5 Trial: Zepbound Shows Greater Weight Loss Than Wegovy
2025-05-14
ASCGT Meeting Navigates Biotech Downturn After Multi-Year Slump
2025-05-14
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top